4. Enhanced patient referral versus simple patient referral, re‐infection in the index patient, effect size.
Comparison |
N (studies) |
n (participants) |
Study ID |
RR (95% CI) |
Test for heterogeneity I2; Chi2, P value |
Home sampling kit vs. simple patient referral | 1 | 220 | Cameron 2009 | 2.14 (0.91 to 5.05) | n/a |
Information booklet vs. simple patient referral | 2 | 942 | Kissinger 2005; Kissinger 2006 | 0.55 (0.22 to 1.33) | 76%; 4.19, P value = 0.04 |
Patient referral (DIS/health adviser) vs. patient referral (nurse) | 1 | 140 | Low 2005 | 0.35 (0.01 to 8.51) | n/a |
Disease‐specific website vs. simple patient referral | 1 | 105 | Tomnay 2006 | 3.12 (0.17 to 58.73) | n/a |
Additional counselling vs. simple patient referral | 1 | 600 | Wilson 2009 | 0.49 (0.27 to 0.89) | n/a |
Enhanced patient referral is taken as the experimental group. Risk ratio (RR) < 1 indicates a lower re‐infection risk after enhanced patient referral than simple patient referral. If RR = 1, the risk of re‐infection is the same in both groups. If RR > 1, there is a higher risk of re‐infection in the enhanced patient referral group. In the trial by Low et al., the outcome was assessed in a minority of index patients.
CI: confidence interval; DIS: disease intervention specialist; n/a: not applicable; RR: risk ratio.